| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/14767058.2017.1401996 |
| P698 | PubMed publication ID | 29113524 |
| P2093 | author name string | Ana L Sarquis | |
| Leonardo B Anizelli | |||
| Lina R Marins | |||
| Mariana D Romanowski | |||
| P2860 | cites work | Neonatal outcomes of premature infants born to preeclamptic mothers. | Q47566352 |
| Preeclampsia and retinopathy of prematurity in preterm births | Q47665000 | ||
| Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood | Q47890265 | ||
| Intrauterine growth retardation in preterm infants ≤32 weeks of gestation is associated with low white blood cell counts | Q48193823 | ||
| Preeclampsia 2012 | Q21285024 | ||
| Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus | Q24241616 | ||
| Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy | Q24645245 | ||
| Neonatal thrombocytopenia: causes and management | Q24673677 | ||
| Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries | Q33264698 | ||
| Prospective, observational study of outcomes in neonates with severe thrombocytopenia | Q33386704 | ||
| Maternal preeclampsia and neonatal outcomes | Q33395211 | ||
| Thrombocytopenia in neonates: causes and outcomes | Q33406581 | ||
| Neonatal thrombocytopenia: etiology, management and outcome | Q33414184 | ||
| Evaluation and management of thrombocytopenic neonates in the intensive care unit | Q33417661 | ||
| Neonatal Thrombocytopenia as a Consequence of Maternal Preeclampsia | Q33430391 | ||
| Time from pre-eclampsia diagnosis to delivery affects future health prospects of children | Q33552791 | ||
| Decreased neutrophil apoptosis in tracheal fluids of preterm infants at risk of chronic lung disease | Q35293350 | ||
| Neonatal neutrophils: the good, the bad, and the ugly | Q35796340 | ||
| Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question | Q35920602 | ||
| Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1. | Q36106483 | ||
| NK cells and pre-eclampsia | Q36812227 | ||
| Mechanisms and potential therapies for preeclampsia | Q37211008 | ||
| Preeclampsia is Characterized by Fetal NK Cell Activation and a Reduction in Regulatory T Cells | Q37225044 | ||
| Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? | Q37302327 | ||
| Sildenafil attenuates placental ischemia-induced hypertension | Q37323529 | ||
| Immune mechanisms at the maternal-fetal interface: perspectives and challenges | Q37351634 | ||
| The global impact of pre-eclampsia and eclampsia | Q37493240 | ||
| Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer | Q37620853 | ||
| Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended? | Q38013410 | ||
| Molecular mechanisms of maternal vascular dysfunction in preeclampsia | Q38300968 | ||
| Maternal pre-eclampsia as a risk factor for necrotizing enterocolitis | Q39537200 | ||
| Th1, Th2, Th17 and Treg levels in umbilical cord blood in preeclampsia | Q40775098 | ||
| Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression | Q41078021 | ||
| Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. | Q43639662 | ||
| Maternal preeclampsia predicts the development of bronchopulmonary dysplasia | Q44700996 | ||
| Pre-eclampsia affects cord blood NK cell expression of activation receptors and serum cytokine levels but not CB monocyte characteristics | Q45385397 | ||
| Maternal preeclampsia is associated with increased risk of necrotizing enterocolitis in preterm infants. | Q46323166 | ||
| Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses | Q46367081 | ||
| Sepsis and neutropenia in very low birth weight infants delivered of mothers with preeclampsia | Q47435751 | ||
| Maternal hypertensive disorders are an independent risk factor for the development of necrotizing enterocolitis in very low birth weight infants. | Q47439575 | ||
| P921 | main subject | pre-eclampsia | Q61335 |
| maternal health | Q6786626 | ||
| P304 | page(s) | 1-8 | |
| P577 | publication date | 2017-11-07 | |
| P1433 | published in | Journal of Maternal-Fetal and Neonatal Medicine | Q6295498 |
| P1476 | title | How does preeclampsia affect neonates? Highlights in the disease's immunity |
| Q60046611 | Components of the antepartum, intrapartum, and postpartum exposome impact on distinct short-term adverse neonatal outcomes of premature infants: A prospective cohort study |
| Q93273515 | Current evidence and outcomes for retinopathy of prematurity prevention: insight into novel maternal and placental contributions |
| Q61844895 | ELABELA plasma concentrations are increased in women with late-onset preeclampsia |
| Q91651753 | Effect of Maternal Preeclampsia on Hematological Profile of Newborns in Qatar |
Search more.